Drawing for ANISTAR

USPTO serial 76071311

ANISTAR

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CARROLL, DORITT
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ANISTAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David R. Owens

ROCHELLE D ALPERT MORGAN, LEWIS & BOCKIUS LLPONE MARKET, SPEAR ST TWRSAN FRANCISCO, CA 94105UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICAL PREPARATIONS, NAMELY, STEROIDSACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 18, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 18, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 18, 2005EX5MSOU EXTENSION 5 DENIAL LETTER MAILED—
Feb 18, 2005EX5DSOU EXTENSION 5 DENIAL LETTER PREPARED—
Feb 8, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 13, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 20, 2004MAILPAPER RECEIVED—
Sep 16, 2004EXT5SOU EXTENSION 5 FILED—
Jul 20, 2004CFITCASE FILE IN TICRS—
May 24, 2004MAILPAPER RECEIVED—
Mar 11, 2004EX4GSOU EXTENSION 4 GRANTED—
Feb 23, 2004MAILPAPER RECEIVED—
Feb 17, 2004EXT4SOU EXTENSION 4 FILED—
Sep 8, 2003EX3GSOU EXTENSION 3 GRANTED—
Sep 8, 2003EXT3SOU EXTENSION 3 FILED—
Sep 8, 2003MAILPAPER RECEIVED—
May 22, 2003EX2GSOU EXTENSION 2 GRANTED—
Mar 21, 2003MAILPAPER RECEIVED—
Mar 18, 2003EXT2SOU EXTENSION 2 FILED—
Oct 30, 2002EX1GSOU EXTENSION 1 GRANTED—
Sep 18, 2002EXT1SOU EXTENSION 1 FILED—
Sep 18, 2002MAILPAPER RECEIVED—
Mar 19, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 25, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 5, 2001NPUBNOTICE OF PUBLICATION—
Jul 9, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 25, 2001CNEAEXAMINERS AMENDMENT MAILED—
Jun 25, 2001DOCKASSIGNED TO EXAMINER—
Jun 25, 2001DOCKASSIGNED TO EXAMINER—
Dec 22, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance